Kora Healthcare Team2026-03-10T09:27:32+00:00March 10th, 2026|
Kora Healthcare acquires BFK Pharma and establishes new pharma subsidiary in Germany Dublin Ireland - 10th March 2026 Kora Healthcare is delighted to announce the acquisition of BFK-Pharma GmbH with offices in Lüneburg and Neurruppin, its first company acquisition in Germany. Following the acquisition, BFK-Pharma
Kora Healthcare Team2026-03-10T09:27:58+00:00February 23rd, 2026|
Sector-specific software helps healthcare suppliers cut supply chain emissions and meet rising buyer requirements Dublin, Ireland – January 2026 – Nocomed, a Dublin-based sustainability software company, is tackling one of healthcare’s least visible but most significant climate challenges: emissions buried deep in supply chains. The
Kora Healthcare Team2025-09-29T12:12:44+01:00September 29th, 2025|
Kora Healthcare is pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Kora Healthcare receiving a Level 2: Comprehensive net zero targets and reporting for carbon emissions. This is key to supporting us
Kora Healthcare Team2025-09-29T12:11:15+01:00September 29th, 2025|
Kora Healthcare is proud to launch our 2024 NHS Carbon Reduction Plan, developed in partnership with Nocomed, a leading life sciences sustainability platform. This strategic initiative underscores our commitment to environmental sustainability, corporate transparency, and data-driven climate action. Key Carbon Emission Reductions (2023–2024): ✅ Scope
Kora Healthcare Team2025-09-29T11:48:21+01:00September 29th, 2025|
We’re thrilled to announce that our sister compnay Arok Healthcare has officially received EU MDR (European Union Medical Device Regulation) certification for our trusted medical device products—Relactagel and Regelle. This regulatory approval marks a major achievement in our commitment to delivering safe, effective, and compliant
Kora Healthcare Team2025-09-29T12:02:25+01:00March 10th, 2025|
Kora Healthcare is pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in us receiving a Level 1: Publicly committed to net zero carbon and engaged with sustainability. The information reported through Evergreen is
Kora Healthcare Team2022-01-24T10:23:59+00:00January 24th, 2022|
SELENASE - KORA HEALTHCARE APPOINTED SELENASE MARKETING AUTHORISATION HOLDER Dublin, Ireland, 24 January 2022. Biosyn Arzneimittel GmbH and Kora Healthcare concluded an exclusive licensing agreement for the continued supply and commercialisation of selenase ® (sodium selenite pentahydrate) in the United Kingdom for the treatment of
Kora Healthcare Team2021-10-04T16:07:19+01:00October 4th, 2021|
Kora Healthcare, an emerging Dublin-based pharma company, today announced it has acquired Chifam Inc, a Canadian-based speciality pharma company focussed on immunotherapy and immune modulation. The acquisition of Chifam Inc by Kora Healthcare is via its Canadian entity Kora Healthcare Canada Inc. No deal terms
Kora Healthcare Team2021-05-04T15:07:06+01:00May 4th, 2021|
Kora Healthcare are delighted to be announced as Winner of the Exporter of the Year award in the SFA National Small Business Awards 2021! The SFA Awards celebrate the achievements of small businesses in Ireland and recognises the important and vital contributions of this sector
lydia2018-09-28T09:36:26+01:00September 28th, 2018|
Kora Healthcare are currently recruiting for a Quality Officer to join our Quality Department. APPLY HERE We are an emerging company committed to identifying, developing and commercialising healthcare products internationally across a spectrum of therapeutic areas. We are dedicated to delivering high quality